ID   XPC_MOUSE               Reviewed;         930 AA.
AC   P51612; P54732; Q3TKI2; Q920M1; Q9DBW7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 2.
DT   13-NOV-2019, entry version 152.
DE   RecName: Full=DNA repair protein complementing XP-C cells homolog;
DE   AltName: Full=Xeroderma pigmentosum group C-complementing protein homolog;
DE   AltName: Full=p125;
GN   Name=Xpc;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-930.
RX   PubMed=8604333; DOI=10.1093/nar/24.6.1026;
RA   Li L., Peterson C., Legerski R.;
RT   "Sequence of the mouse XPC cDNA and genomic structure of the human XPC
RT   gene.";
RL   Nucleic Acids Res. 24:1026-1028(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yokoi M., Hanaoka F.;
RT   "Molecular cloning of mouse XPC.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Lung, and Skin;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 59-617.
RC   STRAIN=129/Sv;
RX   PubMed=7675084; DOI=10.1038/377162a0;
RA   Sands A.T., Abuin A., Sanchez A., Conti C.J., Bradley A.;
RT   "High susceptibility to ultraviolet-induced carcinogenesis in mice
RT   lacking XPC.";
RL   Nature 377:162-165(1995).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-875 AND SER-876, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-875 AND SER-876, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-93; SER-875 AND SER-876,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Involved in global genome nucleotide excision repair
CC       (GG-NER) by acting as damage sensing and DNA-binding factor
CC       component of the XPC complex. Has only a low DNA repair activity
CC       by itself which is stimulated by RAD23B and RAD23A. Has a
CC       preference to bind DNA containing a short single-stranded segment
CC       but not to damaged oligonucleotides. This feature is proposed to
CC       be related to a dynamic sensor function: XPC can rapidly screen
CC       duplex DNA for non-hydrogen-bonded bases by forming a transient
CC       nucleoprotein intermediate complex which matures into a stable
CC       recognition complex through an intrinsic single-stranded DNA-
CC       binding activity. The XPC complex is proposed to represent the
CC       first factor bound at the sites of DNA damage and together with
CC       other core recognition factors, XPA, RPA and the TFIIH complex, is
CC       part of the pre-incision (or initial recognition) complex. The XPC
CC       complex recognizes a wide spectrum of damaged DNA characterized by
CC       distortions of the DNA helix such as single-stranded loops,
CC       mismatched bubbles or single-stranded overhangs. The orientation
CC       of XPC complex binding appears to be crucial for inducing a
CC       productive NER. XPC complex is proposed to recognize and to
CC       interact with unpaired bases on the undamaged DNA strand which is
CC       followed by recruitment of the TFIIH complex and subsequent
CC       scanning for lesions in the opposite strand in a 5'-to-3'
CC       direction by the NER machinery. Cyclobutane pyrimidine dimers
CC       (CPDs) which are formed upon UV-induced DNA damage esacpe
CC       detection by the XPC complex due to a low degree of structural
CC       perurbation. Instead they are detected by the UV-DDB complex which
CC       in turn recruits and cooperates with the XPC complex in the
CC       respective DNA repair. In vitro, the XPC:RAD23B dimer is
CC       sufficient to initiate NER; it preferentially binds to cisplatin
CC       and UV-damaged double-stranded DNA and also binds to a variety of
CC       chemically and structurally diverse DNA adducts. XPC:RAD23B
CC       contacts DNA both 5' and 3' of a cisplatin lesion with a
CC       preference for the 5' side. XPC:RAD23B induces a bend in DNA upon
CC       binding. XPC:RAD23B stimulates the activity of DNA glycosylases
CC       TDG and SMUG1. {ECO:0000250|UniProtKB:Q01831}.
CC   -!- FUNCTION: In absence of DNA repair, the XPC complex also acts as a
CC       transcription coactivator: XPC interacts with the DNA-binding
CC       transcription factor E2F1 at a subset of promoters to recruit
CC       KAT2A and histone acetyltransferase complexes (HAT). KAT2A
CC       recruitment specifically promotes acetylation of histone variant
CC       H2A.Z.1/H2A.Z, but not H2A.Z.2/H2A.V, thereby promoting expression
CC       of target genes. {ECO:0000250|UniProtKB:Q01831}.
CC   -!- SUBUNIT: Component of the XPC complex composed of XPC, RAD23B and
CC       CETN2. Interacts with RAD23A; the interaction is suggesting the
CC       existence of a functional equivalent variant XPC complex.
CC       Interacts with TDG; the interaction is demonstrated using the
CC       XPC:RAD23B dimer. Interacts with SMUG1; the interaction is
CC       demonstrated using the XPC:RAD23B dimer. Interacts with DDB2.
CC       Interacts with CCNH, GTF2H1 and ERCC3. Interacts with E2F1 and
CC       KAT2A; leading to KAT2A recruitment to promoters and subsequent
CC       acetylation of histones. {ECO:0000250|UniProtKB:Q01831}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q01831}.
CC       Chromosome {ECO:0000250|UniProtKB:Q01831}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q01831}. Note=Omnipresent in the nucleus
CC       and consistently associates with and dissociates from DNA in the
CC       absence of DNA damage. Continuously shuttles between the cytoplasm
CC       and the nucleus, which is impeded by the presence of NER lesions.
CC       {ECO:0000250|UniProtKB:Q01831}.
CC   -!- PTM: Ubiquitinated upon UV irradiation; the ubiquitination
CC       requires the UV-DDB complex, appears to be reversible and does not
CC       serve as a signal for degradation. Ubiquitinated by RNF11 via
CC       'Lys-63'-linked ubiquitination. Ubiquitination by RNF111 is
CC       polysumoylation-dependent and promotes nucleotide excision repair.
CC       {ECO:0000250|UniProtKB:Q01831}.
CC   -!- PTM: Sumoylated; sumoylation promotes ubiquitination by RNF111.
CC       {ECO:0000250|UniProtKB:Q01831}.
CC   -!- SIMILARITY: Belongs to the XPC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC52500.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U27398; AAC52500.1; ALT_FRAME; mRNA.
DR   EMBL; AB071144; BAB64540.1; -; mRNA.
DR   EMBL; AK004713; BAB23497.1; -; mRNA.
DR   EMBL; AK028595; BAC26023.1; -; mRNA.
DR   EMBL; AK166981; BAE39163.1; -; mRNA.
DR   EMBL; U40005; AAA82720.1; -; mRNA.
DR   CCDS; CCDS39569.1; -.
DR   PIR; S70630; S70630.
DR   RefSeq; NP_033557.2; NM_009531.2.
DR   SMR; P51612; -.
DR   BioGrid; 204605; 1.
DR   IntAct; P51612; 3.
DR   MINT; P51612; -.
DR   STRING; 10090.ENSMUSP00000032182; -.
DR   iPTMnet; P51612; -.
DR   PhosphoSitePlus; P51612; -.
DR   EPD; P51612; -.
DR   jPOST; P51612; -.
DR   MaxQB; P51612; -.
DR   PaxDb; P51612; -.
DR   PeptideAtlas; P51612; -.
DR   PRIDE; P51612; -.
DR   Ensembl; ENSMUST00000032182; ENSMUSP00000032182; ENSMUSG00000030094.
DR   GeneID; 22591; -.
DR   KEGG; mmu:22591; -.
DR   UCSC; uc009cyd.2; mouse.
DR   CTD; 7508; -.
DR   MGI; MGI:103557; Xpc.
DR   eggNOG; KOG2179; Eukaryota.
DR   eggNOG; COG5535; LUCA.
DR   GeneTree; ENSGT00390000005194; -.
DR   HOGENOM; HOG000124671; -.
DR   InParanoid; P51612; -.
DR   KO; K10838; -.
DR   OMA; EEKWVCV; -.
DR   OrthoDB; 750482at2759; -.
DR   PhylomeDB; P51612; -.
DR   TreeFam; TF101242; -.
DR   Reactome; R-MMU-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-MMU-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-MMU-5696395; Formation of Incision Complex in GG-NER.
DR   ChiTaRS; Xpc; mouse.
DR   PRO; PR:P51612; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   Bgee; ENSMUSG00000030094; Expressed in 258 organ(s), highest expression level in substantia nigra.
DR   ExpressionAtlas; P51612; baseline and differential.
DR   Genevisible; P51612; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; ISO:MGI.
DR   GO; GO:0005730; C:nucleolus; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0000109; C:nucleotide-excision repair complex; ISS:UniProtKB.
DR   GO; GO:0000111; C:nucleotide-excision repair factor 2 complex; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0090734; C:site of DNA damage; IDA:MGI.
DR   GO; GO:0071942; C:XPC complex; ISS:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; IDA:MGI.
DR   GO; GO:0044877; F:protein-containing complex binding; ISS:UniProtKB.
DR   GO; GO:0003697; F:single-stranded DNA binding; ISO:MGI.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:MGI.
DR   GO; GO:0006281; P:DNA repair; IMP:MGI.
DR   GO; GO:0031573; P:intra-S DNA damage checkpoint; IGI:MGI.
DR   GO; GO:0006298; P:mismatch repair; IBA:GO_Central.
DR   GO; GO:0006289; P:nucleotide-excision repair; IDA:MGI.
DR   GO; GO:0000715; P:nucleotide-excision repair, DNA damage recognition; ISO:MGI.
DR   GO; GO:0000720; P:pyrimidine dimer repair by nucleotide-excision repair; IMP:MGI.
DR   GO; GO:1901990; P:regulation of mitotic cell cycle phase transition; ISO:MGI.
DR   GO; GO:0010996; P:response to auditory stimulus; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0010224; P:response to UV-B; IMP:MGI.
DR   GO; GO:0070914; P:UV-damage excision repair; IDA:MGI.
DR   GO; GO:1990731; P:UV-damage excision repair, DNA incision; IMP:MGI.
DR   Gene3D; 3.30.70.2460; -; 1.
DR   Gene3D; 3.90.260.10; -; 1.
DR   InterPro; IPR018327; BHD_2.
DR   InterPro; IPR004583; DNA_repair_Rad4.
DR   InterPro; IPR018026; DNA_repair_Rad4_subgr.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR018325; Rad4/PNGase_transGLS-fold.
DR   InterPro; IPR018326; Rad4_beta-hairpin_dom1.
DR   InterPro; IPR018328; Rad4_beta-hairpin_dom3.
DR   InterPro; IPR042488; Rad4_BHD3_sf.
DR   InterPro; IPR036985; Transglutaminase-like_sf.
DR   PANTHER; PTHR12135; PTHR12135; 1.
DR   Pfam; PF10403; BHD_1; 1.
DR   Pfam; PF10404; BHD_2; 1.
DR   Pfam; PF10405; BHD_3; 1.
DR   Pfam; PF03835; Rad4; 1.
DR   SMART; SM01030; BHD_1; 1.
DR   SMART; SM01031; BHD_2; 1.
DR   SMART; SM01032; BHD_3; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   TIGRFAMs; TIGR00605; rad4; 1.
PE   1: Evidence at protein level;
KW   Chromosome; Complete proteome; Cytoplasm; DNA damage; DNA repair;
KW   DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1    930       DNA repair protein complementing XP-C
FT                                cells homolog.
FT                                /FTId=PRO_0000218294.
FT   REGION      489    727       Interaction with RAD23B. {ECO:0000250}.
FT   REGION      600    759       Minimal sensor domain involved in damage
FT                                recognition. {ECO:0000250}.
FT   REGION      600    734       DNA-binding; preference for heteroduplex
FT                                DNA. {ECO:0000250}.
FT   REGION      760    824       DNA-binding; preference for single
FT                                stranded DNA; required for formation of
FT                                stable nucleoprotein complex.
FT                                {ECO:0000250}.
FT   REGION      809    930       Interaction with ERCC2 and GTF2H1.
FT                                {ECO:0000250}.
FT   REGION      840    859       Interaction with CETN2. {ECO:0000250}.
FT   MOTIF       388    393       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS     27    173       Glu-rich (acidic).
FT   COMPBIAS    355    393       Lys-rich (basic).
FT   COMPBIAS    401    424       Arg/Lys-rich (basic).
FT   COMPBIAS    425    454       Asp/Glu-rich (acidic).
FT   COMPBIAS    459    486       Arg/Lys-rich (basic).
FT   MOD_RES      93     93       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     126    126       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   MOD_RES     165    165       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   MOD_RES     395    395       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   MOD_RES     397    397       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   MOD_RES     875    875       Phosphoserine.
FT                                {ECO:0000244|PubMed:17242355,
FT                                ECO:0000244|PubMed:19144319,
FT                                ECO:0000244|PubMed:21183079}.
FT   MOD_RES     876    876       Phosphoserine.
FT                                {ECO:0000244|PubMed:17242355,
FT                                ECO:0000244|PubMed:19144319,
FT                                ECO:0000244|PubMed:21183079}.
FT   MOD_RES     883    883       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   MOD_RES     895    895       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   CROSSLNK     40     40       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   CROSSLNK     80     80       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   CROSSLNK     88     88       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   CROSSLNK    157    157       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000250|UniProtKB:Q01831}.
FT   CONFLICT     13     13       K -> N (in Ref. 2; BAB64540).
FT                                {ECO:0000305}.
FT   CONFLICT     84     84       L -> S (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT     98     98       F -> L (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    101    101       S -> L (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    148    149       AT -> CP (in Ref. 2; BAB64540).
FT                                {ECO:0000305}.
FT   CONFLICT    165    166       TP -> RG (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    196    201       EVQENM -> GVHEDT (in Ref. 4; AAA82720).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       S -> N (in Ref. 4; AAA82720).
FT                                {ECO:0000305}.
FT   CONFLICT    218    218       S -> N (in Ref. 4; AAA82720).
FT                                {ECO:0000305}.
FT   CONFLICT    221    223       RQP -> SQL (in Ref. 4; AAA82720).
FT                                {ECO:0000305}.
FT   CONFLICT    373    375       GKA -> AKP (in Ref. 4; AAA82720).
FT                                {ECO:0000305}.
FT   CONFLICT    373    373       G -> GS (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    397    397       S -> R (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    454    454       E -> K (in Ref. 2; BAB64540).
FT                                {ECO:0000305}.
FT   CONFLICT    458    458       R -> C (in Ref. 4; AAA82720).
FT                                {ECO:0000305}.
FT   CONFLICT    497    497       S -> C (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    614    614       E -> K (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    621    622       KH -> ND (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    683    683       W -> R (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    712    715       LSEP -> HLGA (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    751    751       N -> K (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    777    777       R -> H (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    797    797       C -> S (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
FT   CONFLICT    921    921       A -> P (in Ref. 1; AAC52500).
FT                                {ECO:0000305}.
SQ   SEQUENCE   930 AA;  104522 MW;  0C469AB21B4E4EE9 CRC64;
     MAPKRTADGR RRKRGQKTED NKVARHEESV ADDFEDEKQK PRRKSSFPKV SQGKRKRGCS
     DPGDPTNGAA KKKVAKATAK SKNLKVLKEE ALSDGDDFRD SPADCKKAKK HPKSKVVDQG
     TDEDDSEDDW EEVEELTEPV LDMGENSATS PSDMPVKAVE IEIETPQQAK ERERSEKIKM
     EFETYLRRMM KRFNKEVQEN MHKVHLLCLL ASGFYRNSIC RQPDLLAIGL SIIPIRFTKV
     PLQDRDAYYL SNLVKWFIGT FTVNADLSAS EQDDLQTTLE RRIAIYSARD NEELVHIFLL
     ILRALQLLTR LVLSLQPIPL KSAVTKGRKS SKETSVEGPG GSSELSSNSP ESHNKPTTSR
     RIKEEETLSE GRGKATARGK RGTGTAGSRQ RRKPSCSEGE EAEQKVQGRP HARKRRVAAK
     VSYKEESESD GAGSGSDFEP SSGEGQHSSD EDCEPGPRKQ KRASAPQRTK AGSKSASKTQ
     RGSQCEPSSF PEASSSSSGC KRGKKVSSGA EEMADRKPAG VDQWLEVYCE PQAKWVCVDC
     VHGVVGQPVA CYKYATKPMT YVVGIDSDGW VRDVTQRYDP AWMTATRKCR VDAEWWAETL
     RPYRSLLTER EKKEDQEFQA KHLDQPLPTS ISTYKNHPLY ALKRHLLKFQ AIYPETAAVL
     GYCRGEAVYS RDCVHTLHSR DTWLKQARVV RLGEVPYKMV KGFSNRARKA RLSEPQLHDH
     NDLGLYGHWQ TEEYQPPIAV DGKVPRNEFG NVYLFLPSMM PVGCVQMTLP NLNRVARKLG
     IDCVQAITGF DFHGGYCHPV TDGYIVCEEF RDVLLAAWEN EQAIIEKKEK EKKEKRALGN
     WKLLVRGLLI RERLKLRYGA KSEAAAPHAA GGGLSSDEEE GTSSQAEAAR VLAASWPQNR
     EDPEQKSEYT KMTRKRRAAE ASHLFPFEKL
//